Fierce Biotech

CBER chief Prasad steps aside, deputy takes the reins as search for successor continues

As the calendar turned from April to May, a big change came to the FDA. | Katherine Szarama, Ph.D., will take over as CBER ...
来自MSN

FDA and EMA unveil stricter biologics compliance agendas

The FDA and EMA have set out updated regulatory agendas that will shape biologics manufacturing standards in coming years. The FDA’s Center for Biologics Evaluation and Research (CBER) 2026 agenda ...